CD274 and neoplasm: In conclusion, the heterogeneous nature of inhibitory immune cells within tumors, influenced by chemokines, cytokines, and colony-stimulating factors in the tumor microenvironment, limits the effectiveness of PD-1/PD-L1 blockers when used alone.